Christopher Ogden, CFO: CytomX Therapeutics CTMX Sell · Filed 03/19

Trade details

Type: Insider sale
Amount: $124,053.66
Shares · price: 19,323 sh · $6.42 a share
Held after: 296,948 sh
Stock: CytomX Therapeutics CTMX
Person: Christopher OgdenCFO
Trade date: 26/03/17
Filed: 26/03/19
Days to filing: 2 days

Sold 6.1% of holdings

Share of holding sold: 6.1%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 02/15~04/16

Christopher Ogden's recent trades

Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$4,953
1,624 sh
$4,953
Filed 06/17
Traded 06/15
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$28.6K
10,614 sh
$28.6K
Filed 25/06/17
Traded 25/06/16
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$4,841
1,641 sh
$4,841
Filed 25/06/17
Traded 25/06/13
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,131
8,551 sh
$5,131
Filed 25/03/20
Traded 25/03/18
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$2,440
1,984 sh
$2,440
Filed 24/08/22
Traded 24/08/20